In contrast to BCL2, which we have shown to be predominantly expressed in a subset of PCa tumors with lineage plasticity, MCL1 and BCLXL are highly expressed in the majority of PCa tumors, associating with inferior clinical outcomes.6 The gene discussed is BCL2; the disease is posterior cortical atrophy.